Market Overview:
The global H2 receptor blocker market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders, rising geriatric population, and growing demand for minimally invasive surgeries. By type, the cimetidine segment is expected to lead the global H2 receptor blocker market during the forecast period. By application, hospitals are expected to account for the largest share of the global H2 receptor blocker market in 2018.
Product Definition:
H2 receptor blockers are drugs that block the action of histamine on H2 receptors. They are used to treat conditions such as peptic ulcers and gastroesophageal reflux disease.
Cimetidine:
Cimetidine is a histamine2 receptor (H2) blocker. It works by decreasing the amount of acid produced in the stomach. Acid production decreases when taken in conjunction with antacids, which neutralizes the acid and prevents heartburn or indigestion. Cimetidine has been used for many years as an anti-ulcer drug but was recently found to be useful for other purposes such as treatment against cancer cells and reducing blood sugar levels after meals.
Ranitidine:
Ranitidine is a histamine H2 receptor antagonist used in the treatment of stomach ulcers, peptic ulcer disease and gastroesophageal reflux. It works by blocking the action of acid produced by the stomach lining on itself and therefore reduces the damage to cells that line it. Ranitidine has been approved for use as an anti-ulcer drug by both U.S. FDA (Food & Drug Administration) and European Medicines Agency (EMA).
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and ambulatory surgical centers. Hospitals held the largest share of over 70.0% in 2017 owing to high usage of anti-diarrheal drugs such as loperamide (Imodium) and metoclopramide (Mylotrol) for diarrhea treatment in hospital settings. Furthermore, increasing prevalence of chronic diseases such as heart disease, cancer and diabetes is expected to drive demand for anti-diarrheal drugs which will further increase the use of H2 receptor blockers in hospitals during upcoming years.
The clinics segment is anticipated to witness significant growth over the forecast period due to rising awareness regarding digestive health issues coupled with growing geriatric population base that requires regular checkups at clinics or walk-in medical centers.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some factors responsible for its growth. In addition, the U.S., which is at the forefront of this region with a revenue share of over 80% in 2017 is experiencing an increase in geriatric population prone to digestive system disorders such as gastric ulcers and duodenal ulcers that can be treated effectively with H2 receptor blockers thus driving their demand.
Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising disposable income leading to increased adoption of medical services including ambulatory surgical centers and hospitals thus propelling market growth.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for H2 receptor blockers in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options. This is likely to boost the demand for H2 receptor blockers in the near future.
- Rising number of product approvals: The number of product approvals for H2 receptor blockers has been rising in recent years, owing to their therapeutic potential in treating various respiratory diseases. This is likely to propel the growth of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
H2 Receptor Blocker Market Research Report
By Type
Cimetidine, Ranitidine, Nizatidine, Others
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
GSK, Medochemie, Horizon Pharma, ZAFA Pharmaceutical, Merck, Incepta Pharmaceuticals Limited, Britannica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global H2 Receptor Blocker Market Report Segments:
The global H2 Receptor Blocker market is segmented on the basis of:
Types
Cimetidine, Ranitidine, Nizatidine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Medochemie
- Horizon Pharma
- ZAFA Pharmaceutical
- Merck
- Incepta Pharmaceuticals Limited
- Britannica
Highlights of The H2 Receptor Blocker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cimetidine
- Ranitidine
- Nizatidine
- Others
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the H2 Receptor Blocker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A H2 receptor blocker is a medication that blocks the action of histamine, which is a type of chemical messenger in the body. Histamine can cause inflammation and other problems in the body. By blocking the action of histamine, H2 receptor blockers may help to reduce these symptoms.
Some of the major companies in the h2 receptor blocker market are GSK, Medochemie, Horizon Pharma, ZAFA Pharmaceutical, Merck, Incepta Pharmaceuticals Limited, Britannica.
The h2 receptor blocker market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 H2 Receptor Blocker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 H2 Receptor Blocker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 H2 Receptor Blocker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the H2 Receptor Blocker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global H2 Receptor Blocker Market Size & Forecast, 2020-2028
4.5.1 H2 Receptor Blocker Market Size and Y-o-Y Growth
4.5.2 H2 Receptor Blocker Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cimetidine
5.2.2 Ranitidine
5.2.3 Nizatidine
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global H2 Receptor Blocker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 H2 Receptor Blocker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cimetidine
9.6.2 Ranitidine
9.6.3 Nizatidine
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cimetidine
10.6.2 Ranitidine
10.6.3 Nizatidine
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cimetidine
11.6.2 Ranitidine
11.6.3 Nizatidine
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cimetidine
12.6.2 Ranitidine
12.6.3 Nizatidine
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cimetidine
13.6.2 Ranitidine
13.6.3 Nizatidine
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 H2 Receptor Blocker Market: Competitive Dashboard
14.2 Global H2 Receptor Blocker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Medochemie
14.3.3 Horizon Pharma
14.3.4 ZAFA Pharmaceutical
14.3.5 Merck
14.3.6 Incepta Pharmaceuticals Limited
14.3.7 Britannica
